Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Marburg virus"" wg kryterium: Temat


Starter badań:

Tytuł :
Combination therapy protects macaques against advanced Marburg virus disease.
Autorzy :
Cross RW; Galveston National Laboratory, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, USA.
Bornholdt ZA; Mapp Biopharmaceutical, Inc., 6160 Lusk Blvd Ste C200, San Diego, CA, USA.
Prasad AN; Galveston National Laboratory, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, USA.
Borisevich V; Galveston National Laboratory, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, USA.
Agans KN; Galveston National Laboratory, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, USA.
Deer DJ; Galveston National Laboratory, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, USA.
Abelson DM; Mapp Biopharmaceutical, Inc., 6160 Lusk Blvd Ste C200, San Diego, CA, USA.
Kim DH; Mapp Biopharmaceutical, Inc., 6160 Lusk Blvd Ste C200, San Diego, CA, USA.
Shestowsky WS; Mapp Biopharmaceutical, Inc., 6160 Lusk Blvd Ste C200, San Diego, CA, USA.
Campbell LA; Mapp Biopharmaceutical, Inc., 6160 Lusk Blvd Ste C200, San Diego, CA, USA.
Bunyan E; Gilead Sciences, Inc., 333 Lakeside Dr, Foster City, CA, USA.
Geisbert JB; Galveston National Laboratory, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, USA.
Fenton KA; Galveston National Laboratory, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, USA.
Zeitlin L; Mapp Biopharmaceutical, Inc., 6160 Lusk Blvd Ste C200, San Diego, CA, USA. .
Porter DP; Gilead Sciences, Inc., 333 Lakeside Dr, Foster City, CA, USA. .
Geisbert TW; Galveston National Laboratory, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, USA. .; Department of Microbiology and Immunology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Mar 25; Vol. 12 (1), pp. 1891. Date of Electronic Publication: 2021 Mar 25.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Adenosine Monophosphate/*analogs & derivatives
Alanine/*analogs & derivatives
Antibodies, Monoclonal/*therapeutic use
Antibodies, Viral/*therapeutic use
Marburg Virus Disease/*drug therapy
Marburgvirus/*drug effects
Adenosine Monophosphate/therapeutic use ; Alanine/therapeutic use ; Animals ; Disease Models, Animal ; Drug Therapy, Combination ; Macaca mulatta ; Marburg Virus Disease/prevention & control ; Viral Load/drug effects
Czasopismo naukowe
Tytuł :
Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictions.
Autorzy :
Bozhanova NG; Department of Chemistry, Vanderbilt University, Nashville, TN 37235.; Center for Structural Biology, Vanderbilt University, Nashville, TN 37235.
Sangha AK; Department of Chemistry, Vanderbilt University, Nashville, TN 37235.; Center for Structural Biology, Vanderbilt University, Nashville, TN 37235.
Sevy AM; Center for Structural Biology, Vanderbilt University, Nashville, TN 37235.; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232.
Gilchuk P; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232.
Huang K; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77550.
Nargi RS; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232.
Reidy JX; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232.
Trivette A; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232.
Carnahan RH; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232.; Department of Pediatrics, Vanderbilt University Medical Center, Nashville TN 37232.
Bukreyev A; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77550.; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555.
Crowe JE Jr; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232.; Department of Pediatrics, Vanderbilt University Medical Center, Nashville TN 37232.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232.
Meiler J; Department of Chemistry, Vanderbilt University, Nashville, TN 37235; .; Center for Structural Biology, Vanderbilt University, Nashville, TN 37235.; Institute for Drug Discovery, Leipzig University Medical School, Leipzig, SAC 04103, Germany.
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Dec 08; Vol. 117 (49), pp. 31142-31148. Date of Electronic Publication: 2020 Nov 23.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Antibodies, Viral/*genetics
Complementarity Determining Regions/*genetics
Marburg Virus Disease/*immunology
Marburgvirus/*immunology
Animals ; Antibodies, Neutralizing/genetics ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; Complementarity Determining Regions/immunology ; Epitopes/genetics ; Epitopes/immunology ; Glycoproteins/genetics ; Glycoproteins/immunology ; Humans ; Immunoglobulin Heavy Chains/genetics ; Immunoglobulin Heavy Chains/immunology ; Marburg Virus Disease/drug therapy ; Marburg Virus Disease/genetics ; Marburg Virus Disease/virology ; Marburgvirus/pathogenicity ; Mutation/genetics ; Mutation/immunology ; Viral Envelope Proteins ; Viral Vaccines/genetics ; Viral Vaccines/immunology
Czasopismo naukowe
Tytuł :
Remdesivir (GS-5734) Is Efficacious in Cynomolgus Macaques Infected With Marburg Virus.
Autorzy :
Porter DP; Gilead Sciences Inc., Foster City, California, USA.
Weidner JM; Geneva Foundation, Tacoma, Washington, USA.; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Gomba L; Geneva Foundation, Tacoma, Washington, USA.; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Bannister R; Gilead Sciences Inc., Foster City, California, USA.
Blair C; Gilead Sciences Inc., Foster City, California, USA.
Jordan R; Gilead Sciences Inc., Foster City, California, USA.
Wells J; Geneva Foundation, Tacoma, Washington, USA.; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Wetzel K; Geneva Foundation, Tacoma, Washington, USA.; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Garza N; Geneva Foundation, Tacoma, Washington, USA.; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Van Tongeren S; Geneva Foundation, Tacoma, Washington, USA.; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Donnelly G; Geneva Foundation, Tacoma, Washington, USA.; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Steffens J; Geneva Foundation, Tacoma, Washington, USA.; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Moreau A; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Bearss J; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Lee E; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Bavari S; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Cihlar T; Gilead Sciences Inc., Foster City, California, USA.
Warren TK; Geneva Foundation, Tacoma, Washington, USA.; United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2020 Nov 09; Vol. 222 (11), pp. 1894-1901.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Antimetabolites/*therapeutic use
Antiviral Agents/*therapeutic use
Marburg Virus Disease/*drug therapy
Marburgvirus/*drug effects
Monkey Diseases/*drug therapy
Adenosine Monophosphate/analogs & derivatives ; Alanine/analogs & derivatives ; Animals ; Disease Models, Animal ; Female ; Kaplan-Meier Estimate ; Macaca fascicularis ; Male ; Marburg Virus Disease/mortality ; Marburg Virus Disease/pathology ; Marburg Virus Disease/virology ; Monkey Diseases/mortality ; Monkey Diseases/pathology ; Monkey Diseases/virology ; RNA, Viral
Czasopismo naukowe
Tytuł :
Marburg virus disease: A summary for clinicians.
Autorzy :
Kortepeter MG; University of Nebraska Medical Center, Omaha, NE, USA. Electronic address: .
Dierberg K; Bellevue Hospital Center, New York, NY, USA.
Shenoy ES; Massachusetts General Hospital, Boston, MA, USA.
Cieslak TJ; University of Nebraska Medical Center, Omaha, NE, USA.
Pokaż więcej
Corporate Authors :
Medical Countermeasures Working Group of the National Ebola Training and Education Center's (NETEC) Special Pathogens Research Network (SPRN)
Źródło :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2020 Oct; Vol. 99, pp. 233-242. Date of Electronic Publication: 2020 Aug 03.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Marburg Virus Disease/*therapy
Animals ; Humans ; Marburg Virus Disease/immunology ; Marburg Virus Disease/prevention & control ; Marburg Virus Disease/virology ; Marburgvirus/immunology ; Viral Vaccines/administration & dosage ; Viral Vaccines/immunology
Czasopismo naukowe
Tytuł :
Shedding of Marburg Virus in Naturally Infected Egyptian Rousette Bats, South Africa, 2017.
Autorzy :
Pawęska JT
Storm N
Markotter W
Di Paola N
Wiley MR
Palacios G
Jansen van Vuren P
Pokaż więcej
Źródło :
Emerging infectious diseases [Emerg Infect Dis] 2020 Dec; Vol. 26 (12), pp. 3051-3055.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Chiroptera*
Marburg Virus Disease*/epidemiology
Marburgvirus*/genetics
Animals ; Humans ; South Africa/epidemiology
Czasopismo naukowe
Tytuł :
A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda.
Autorzy :
Nyakarahuka L; Arbovirology, Emerging and Re-emerging Diseases, Uganda Virus Research Institute , Entebbe, Uganda. .; Department of Biosecurity, Ecosystems and Veterinary Public Health, College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala, Uganda. .
Schafer IJ; Centres for Disease Control and Prevention, Atlanta, USA.
Balinandi S; Arbovirology, Emerging and Re-emerging Diseases, Uganda Virus Research Institute , Entebbe, Uganda.
Mulei S; Arbovirology, Emerging and Re-emerging Diseases, Uganda Virus Research Institute , Entebbe, Uganda.
Tumusiime A; Arbovirology, Emerging and Re-emerging Diseases, Uganda Virus Research Institute , Entebbe, Uganda.
Kyondo J; Arbovirology, Emerging and Re-emerging Diseases, Uganda Virus Research Institute , Entebbe, Uganda.
Knust B; Centres for Disease Control and Prevention, Atlanta, USA.
Lutwama J; Arbovirology, Emerging and Re-emerging Diseases, Uganda Virus Research Institute , Entebbe, Uganda.
Rollin P; Centres for Disease Control and Prevention, Atlanta, USA.
Nichol S; Centres for Disease Control and Prevention, Atlanta, USA.
Shoemaker T; Centres for Disease Control and Prevention, Atlanta, USA.
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2020 Jul 01; Vol. 20 (1), pp. 461. Date of Electronic Publication: 2020 Jul 01.
Typ publikacji :
Journal Article
MeSH Terms :
Disease Outbreaks*
Ebolavirus/*immunology
Hemorrhagic Fever, Ebola/*diagnosis
Hemorrhagic Fever, Ebola/*epidemiology
Marburg Virus Disease/*diagnosis
Marburg Virus Disease/*epidemiology
Marburgvirus/*immunology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Animals ; Child ; Child, Preschool ; Chiroptera/virology ; Enzyme-Linked Immunosorbent Assay ; Female ; Hemorrhagic Fever, Ebola/blood ; Humans ; Male ; Marburg Virus Disease/blood ; Middle Aged ; Miners ; Retrospective Studies ; Seroepidemiologic Studies ; Uganda/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Viral genomics in Ebola virus research.
Autorzy :
Di Paola N; United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, USA.
Sanchez-Lockhart M; United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, USA.
Zeng X; United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, USA.
Kuhn JH; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.
Palacios G; United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, USA. .
Pokaż więcej
Źródło :
Nature reviews. Microbiology [Nat Rev Microbiol] 2020 Jul; Vol. 18 (7), pp. 365-378. Date of Electronic Publication: 2020 May 04.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Ebolavirus/*genetics
Hemorrhagic Fever, Ebola/*epidemiology
Host-Pathogen Interactions/*genetics
Marburg Virus Disease/*epidemiology
Marburgvirus/*genetics
Africa/epidemiology ; Animals ; Disease Outbreaks ; Female ; Genome, Viral/genetics ; Genomics/methods ; Hemorrhagic Fever, Ebola/pathology ; Hemorrhagic Fever, Ebola/transmission ; Humans ; Male ; Marburg Virus Disease/pathology ; Marburg Virus Disease/transmission ; Molecular Epidemiology/methods ; Reverse Genetics/methods ; Virus Replication/genetics
Czasopismo naukowe
Tytuł :
Previremic Identification of Ebola or Marburg Virus Infection Using Integrated Host-Transcriptome and Viral Genome Detection.
Autorzy :
Speranza E; Boston University School of Medicine, Department of Microbiology and National Infectious Diseases Laboratories, Boston, Massachusetts, USA.; Bioinformatics Program, Boston University, Boston, Massachusetts, USA.
Caballero I; Boston University School of Medicine, Department of Microbiology and National Infectious Diseases Laboratories, Boston, Massachusetts, USA.
Honko AN; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA.
Johnson JC; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA.
Bohannon JK; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA.
Evans DeWald L; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA.
Gerhardt DM; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA.
Sword J; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA.
Hensley LE; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA.
Bennett RS; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA.
Connor JH; Boston University School of Medicine, Department of Microbiology and National Infectious Diseases Laboratories, Boston, Massachusetts, USA .; Bioinformatics Program, Boston University, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
MBio [mBio] 2020 Jun 16; Vol. 11 (3). Date of Electronic Publication: 2020 Jun 16.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms :
Genome, Viral*
Transcriptome*
Hemorrhagic Fever, Ebola/*diagnosis
Host-Pathogen Interactions/*genetics
Marburg Virus Disease/*diagnosis
RNA, Viral/*isolation & purification
Animals ; Ebolavirus/genetics ; Hemorrhagic Fever, Ebola/virology ; Humans ; Macaca ; Marburg Virus Disease/virology ; Marburgvirus/genetics ; Microarray Analysis ; Viral Proteins/blood ; Viral Proteins/genetics ; Viremia
Czasopismo naukowe
Tytuł :
MARVellous Sidekick Antibodies.
Autorzy :
Mouquet H; Laboratory of Humoral Immunology, Department of Immunology, Institut Pasteur, Paris, France; INSERM U1222, Paris, France. Electronic address: .
Pokaż więcej
Źródło :
Cell host & microbe [Cell Host Microbe] 2020 Jun 10; Vol. 27 (6), pp. 856-858.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Marburg Virus Disease*
Marburgvirus/*immunology
Animals ; Antibodies, Monoclonal ; Antibodies, Viral ; Humans ; Survivors
Czasopismo naukowe
Tytuł :
Immune correlates of postexposure vaccine protection against Marburg virus.
Autorzy :
Woolsey C; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Jankeel A; Department of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, Irvine, CA, 92697, USA.
Matassov D; Department of Virology and Vaccine Vectors, Profectus BioSciences Inc., Pearl River, NY, 10965, USA.
Geisbert JB; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Agans KN; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Borisevich V; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Cross RW; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Deer DJ; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Fenton KA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Latham TE; Department of Virology and Vaccine Vectors, Profectus BioSciences Inc., Pearl River, NY, 10965, USA.
Gerardi CS; Department of Virology and Vaccine Vectors, Profectus BioSciences Inc., Pearl River, NY, 10965, USA.
Mire CE; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Eldridge JH; Department of Virology and Vaccine Vectors, Profectus BioSciences Inc., Pearl River, NY, 10965, USA.; Department of Immunology, Profectus BioSciences Inc., Pearl River, NY, 10965, USA.
Messaoudi I; Department of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, Irvine, CA, 92697, USA.
Geisbert TW; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA. .; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Feb 20; Vol. 10 (1), pp. 3071. Date of Electronic Publication: 2020 Feb 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Post-Exposure Prophylaxis*
Marburg Virus Disease/*immunology
Marburg Virus Disease/*virology
Marburgvirus/*immunology
Viral Vaccines/*immunology
Animals ; Antibodies, Viral/biosynthesis ; Antibodies, Viral/immunology ; Cytokines/blood ; Cytotoxicity, Immunologic ; Dose-Response Relationship, Immunologic ; Down-Regulation/genetics ; Female ; Inflammation/blood ; Inflammation/immunology ; Interferons/genetics ; Interferons/metabolism ; Killer Cells, Natural/immunology ; Macaca mulatta/immunology ; Macaca mulatta/virology ; Male ; Marburg Virus Disease/blood ; Marburg Virus Disease/genetics ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Recombination, Genetic/genetics ; T-Lymphocytes, Helper-Inducer/immunology ; Th1 Cells/immunology ; Th2 Cells/immunology ; Transcriptome/genetics ; Up-Regulation/genetics ; Vesiculovirus/genetics ; Viral Load/immunology
Czasopismo naukowe
Tytuł :
Seroreactivity against Marburg or related filoviruses in West and Central Africa.
Autorzy :
Steffen I; Vitalant Research Institute, San Francisco, CA, USA.; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Lu K; Vitalant Research Institute, San Francisco, CA, USA.; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Hoff NA; Department of Epidemiology, School of Public Health, University of California Los Angeles, Los Angeles, CA, USA.
Mulembakani P; Kinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Okitolonda Wemakoy E; Kinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Muyembe-Tamfum JJ; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
Ndembi N; Institute of Human Virology, Abuja, Nigeria.
Brennan CA; Abbott Diagnostics, Abbott Park, IL, USA.
Hackett J Jr; Abbott Diagnostics, Abbott Park, IL, USA.
Switzer WM; Centers for Disease Control and Prevention, Atlanta, GA, USA.
Saragosti S; INSERM U941, Paris, France.
Mbensa GO; Centre National de Transfusion Sanguine, Kinshasa, Democratic Republic of Congo.
Laperche S; Institut National de la Transfusion Sanguine, Paris, France.
Rimoin AW; Department of Epidemiology, School of Public Health, University of California Los Angeles, Los Angeles, CA, USA.
Simmons G; Vitalant Research Institute, San Francisco, CA, USA.; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Pokaż więcej
Źródło :
Emerging microbes & infections [Emerg Microbes Infect] 2020 Jan 08; Vol. 9 (1), pp. 124-128. Date of Electronic Publication: 2020 Jan 08 (Print Publication: 2020).
Typ publikacji :
Letter
MeSH Terms :
Antibodies, Viral/*blood
Filoviridae/*immunology
Marburg Virus Disease/*blood
Marburg Virus Disease/*epidemiology
Marburgvirus/*immunology
Animals ; Cameroon/epidemiology ; Enzyme-Linked Immunosorbent Assay ; Filoviridae/genetics ; Filoviridae Infections/blood ; Filoviridae Infections/epidemiology ; Filoviridae Infections/virology ; Ghana/epidemiology ; Humans ; Marburg Virus Disease/virology ; Marburgvirus/genetics ; Retrospective Studies ; Seroepidemiologic Studies
Opinia redakcyjna
Tytuł :
'When I die, let me be the last.' Community health worker perspectives on past Ebola and Marburg outbreaks in Uganda.
Autorzy :
Englert EG; a Feinberg School of Medicine, Northwestern University , Chicago , IL , USA.; b Kellogg Institute for International Studies, University of Notre Dame , Notre Dame , IN , USA.
Kiwanuka R; c Palliative Care Association of Uganda , Kampala , Uganda.
Neubauer LC; a Feinberg School of Medicine, Northwestern University , Chicago , IL , USA.
Pokaż więcej
Źródło :
Global public health [Glob Public Health] 2019 Aug; Vol. 14 (8), pp. 1182-1192. Date of Electronic Publication: 2018 Dec 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hemorrhagic Fever, Ebola*/mortality
Marburg Virus Disease*/mortality
Community Health Workers/*psychology
Survivors/*psychology
Animals ; Communicable Disease Control ; Disease Outbreaks ; Female ; Humans ; Interviews as Topic ; Male ; Qualitative Research ; Uganda/epidemiology
Czasopismo naukowe
Tytuł :
Marburg haemorrhagic fever in returning travellers: an overview aimed at clinicians.
Autorzy :
Bauer MP; Department of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands.
Timen A; National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Vossen ACTM; Department Medical Microbiology, Leiden University Medical Centre, Leiden, The Netherlands.
van Dissel JT; Department of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2019 Apr; Vol. 21S, pp. e28-e31. Date of Electronic Publication: 2015 Jun 22.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Travel-Related Illness*
Marburg Virus Disease/*diagnosis
Marburg Virus Disease/*prevention & control
Marburgvirus/*isolation & purification
Animals ; Disease Outbreaks/prevention & control ; Early Diagnosis ; Humans ; Infection Control ; Marburg Virus Disease/pathology ; Marburg Virus Disease/therapy ; Marburgvirus/pathogenicity
Czasopismo naukowe
Tytuł :
Monoterpenoid-based inhibitors of filoviruses targeting the glycoprotein-mediated entry process.
Autorzy :
Sokolova AS; N.N.Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS, 630090, Novosibirsk, Lavrent'ev Av., 9, Russia. Electronic address: .
Yarovaya OI; N.N.Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS, 630090, Novosibirsk, Lavrent'ev Av., 9, Russia; Novosibirsk State University, 630090, Novosibirsk, Pirogova St., 1, Russia.
Zybkina AV; State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559, Koltsovo, Novosibirsk Region, Russia.
Mordvinova ED; N.N.Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS, 630090, Novosibirsk, Lavrent'ev Av., 9, Russia; State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559, Koltsovo, Novosibirsk Region, Russia.
Shcherbakova NS; State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559, Koltsovo, Novosibirsk Region, Russia.
Zaykovskaya AV; State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559, Koltsovo, Novosibirsk Region, Russia.
Baev DS; N.N.Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS, 630090, Novosibirsk, Lavrent'ev Av., 9, Russia.
Tolstikova TG; N.N.Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS, 630090, Novosibirsk, Lavrent'ev Av., 9, Russia; Novosibirsk State University, 630090, Novosibirsk, Pirogova St., 1, Russia.
Shcherbakov DN; State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559, Koltsovo, Novosibirsk Region, Russia.
Pyankov OV; State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559, Koltsovo, Novosibirsk Region, Russia.
Maksyutov RA; State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559, Koltsovo, Novosibirsk Region, Russia.
Salakhutdinov NF; N.N.Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS, 630090, Novosibirsk, Lavrent'ev Av., 9, Russia.
Pokaż więcej
Źródło :
European journal of medicinal chemistry [Eur J Med Chem] 2020 Dec 01; Vol. 207, pp. 112726. Date of Electronic Publication: 2020 Aug 20.
Typ publikacji :
Journal Article
MeSH Terms :
Antiviral Agents/*chemistry
Antiviral Agents/*pharmacology
Ebolavirus/*drug effects
Marburgvirus/*drug effects
Monoterpenes/*chemistry
Monoterpenes/*pharmacology
Animals ; Antiviral Agents/toxicity ; Ebolavirus/physiology ; HEK293 Cells ; Hemorrhagic Fever, Ebola/drug therapy ; Humans ; Marburg Virus Disease/drug therapy ; Marburgvirus/physiology ; Mice, Inbred ICR ; Molecular Docking Simulation ; Monoterpenes/toxicity ; Virus Internalization
Czasopismo naukowe
Tytuł :
Antibody-Mediated Virus Neutralization Is Not a Universal Mechanism of Marburg, Ebola, or Sosuga Virus Clearance in Egyptian Rousette Bats.
Autorzy :
Schuh AJ; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta.; Commissioned Corps, US Public Health Service, Rockville, Maryland.
Amman BR; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta.
Sealy TK; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta.
Kainulainen MH; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta.
Chakrabarti AK; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta.
Guerrero LW; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta.
Nichol ST; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta.
Albarino CG; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta.
Towner JS; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta.; Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, Georgia.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2019 May 05; Vol. 219 (11), pp. 1716-1721.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Chiroptera/*virology
Ebolavirus/*immunology
Hemorrhagic Fever, Ebola/*immunology
Marburg Virus Disease/*immunology
Marburgvirus/*immunology
Paramyxoviridae/*immunology
Animals ; Antibodies, Viral/immunology ; Convalescence ; Disease Reservoirs/virology ; Egypt/epidemiology ; Hemorrhagic Fever, Ebola/virology ; Humans ; Immunity, Humoral ; Marburg Virus Disease/virology ; Neutralization Tests
Czasopismo naukowe
Tytuł :
Marburg virus disease outbreak in Kween District Uganda, 2017: Epidemiological and laboratory findings.
Autorzy :
Nyakarahuka L; Department of Arbovirology, Emerging and Re-emerging Infections, Uganda Virus Research Institute (UVRI), Entebbe Uganda.; Department of Biosecurity, Ecosystems, and Veterinary Public Health, Collage of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala Uganda.
Shoemaker TR; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention (CDC), Atlanta, GA United States of America.
Balinandi S; Department of Arbovirology, Emerging and Re-emerging Infections, Uganda Virus Research Institute (UVRI), Entebbe Uganda.
Chemos G; Kween District Health Team, Kween District Local Government, Kween, Uganda.
Kwesiga B; Uganda Public Health Fellowship Program, Ministry of Health, Kampala, Uganda.
Mulei S; Department of Arbovirology, Emerging and Re-emerging Infections, Uganda Virus Research Institute (UVRI), Entebbe Uganda.
Kyondo J; Department of Arbovirology, Emerging and Re-emerging Infections, Uganda Virus Research Institute (UVRI), Entebbe Uganda.
Tumusiime A; Department of Arbovirology, Emerging and Re-emerging Infections, Uganda Virus Research Institute (UVRI), Entebbe Uganda.
Kofman A; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention (CDC), Atlanta, GA United States of America.
Masiira B; African Field Epidemiology Network, Kampala, Uganda.
Whitmer S; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention (CDC), Atlanta, GA United States of America.
Brown S; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention (CDC), Atlanta, GA United States of America.
Cannon D; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention (CDC), Atlanta, GA United States of America.
Chiang CF; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention (CDC), Atlanta, GA United States of America.
Graziano J; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention (CDC), Atlanta, GA United States of America.
Morales-Betoulle M; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention (CDC), Atlanta, GA United States of America.
Patel K; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention (CDC), Atlanta, GA United States of America.
Zufan S; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention (CDC), Atlanta, GA United States of America.
Komakech I; World Health Organization - Country Office, Kampala, Uganda.
Natseri N; World Health Organization - Country Office, Kampala, Uganda.
Chepkwurui PM; Kween District Health Team, Kween District Local Government, Kween, Uganda.
Lubwama B; Ministry of Health, Kampala, Uganda.
Okiria J; Ministry of Health, Kampala, Uganda.
Kayiwa J; Public Health Emergency Operations Center, Ministry of Health, Kampala, Uganda.
Nkonwa IH; Uganda Public Health Fellowship Program, Ministry of Health, Kampala, Uganda.
Eyu P; Uganda Public Health Fellowship Program, Ministry of Health, Kampala, Uganda.
Nakiire L; Uganda Public Health Fellowship Program, Ministry of Health, Kampala, Uganda.
Okarikod EC; Kween District Health Team, Kween District Local Government, Kween, Uganda.
Cheptoyek L; Kween District Health Team, Kween District Local Government, Kween, Uganda.
Wangila BE; Kween District Health Team, Kween District Local Government, Kween, Uganda.
Wanje M; Kween District Health Team, Kween District Local Government, Kween, Uganda.
Tusiime P; Ministry of Health, Kampala, Uganda.
Bulage L; Uganda Public Health Fellowship Program, Ministry of Health, Kampala, Uganda.
Mwebesa HG; Ministry of Health, Kampala, Uganda.
Ario AR; Uganda Public Health Fellowship Program, Ministry of Health, Kampala, Uganda.
Makumbi I; Public Health Emergency Operations Center, Ministry of Health, Kampala, Uganda.
Nakinsige A; Ministry of Health, Kampala, Uganda.
Muruta A; Ministry of Health, Kampala, Uganda.
Nanyunja M; World Health Organization - Country Office, Kampala, Uganda.
Homsy J; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention (CDC), Atlanta, GA United States of America.
Zhu BP; Uganda Public Health Fellowship Program, Ministry of Health, Kampala, Uganda.
Nelson L; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention (CDC), Atlanta, GA United States of America.
Kaleebu P; Department of Arbovirology, Emerging and Re-emerging Infections, Uganda Virus Research Institute (UVRI), Entebbe Uganda.
Rollin PE; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention (CDC), Atlanta, GA United States of America.
Nichol ST; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention (CDC), Atlanta, GA United States of America.
Klena JD; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention (CDC), Atlanta, GA United States of America.
Lutwama JJ; Department of Arbovirology, Emerging and Re-emerging Infections, Uganda Virus Research Institute (UVRI), Entebbe Uganda.
Pokaż więcej
Źródło :
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2019 Mar 18; Vol. 13 (3), pp. e0007257. Date of Electronic Publication: 2019 Mar 18 (Print Publication: 2019).
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Disease Outbreaks*
Clinical Laboratory Techniques/*methods
Communicable Disease Control/*methods
Marburg Virus Disease/*epidemiology
Marburg Virus Disease/*pathology
Marburgvirus/*isolation & purification
Adult ; Animals ; Cluster Analysis ; Disease Transmission, Infectious/prevention & control ; Family Health ; Female ; High-Throughput Nucleotide Sequencing ; Humans ; Male ; Marburg Virus Disease/mortality ; Middle Aged ; Mortality ; Uganda/epidemiology ; Virus Cultivation
Czasopismo naukowe
Tytuł :
Clinical, Histopathologic, and Immunohistochemical Characterization of Experimental Marburg Virus Infection in A Natural Reservoir Host, the Egyptian Rousette Bat ( Rousettus aegyptiacus ).
Autorzy :
Jones MEB; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30029, USA. .; Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA. .
Amman BR; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30029, USA. .
Sealy TK; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30029, USA. .
Uebelhoer LS; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30029, USA. .
Schuh AJ; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30029, USA. .
Flietstra T; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30029, USA. .
Bird BH; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30029, USA. .
Coleman-McCray JD; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30029, USA. .
Zaki SR; Infectious Diseases Pathology Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA. .
Nichol ST; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30029, USA. .
Towner JS; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30029, USA. .; Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA. .
Pokaż więcej
Źródło :
Viruses [Viruses] 2019 Mar 02; Vol. 11 (3). Date of Electronic Publication: 2019 Mar 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Chiroptera/*virology
Disease Reservoirs/*virology
Liver/*virology
Marburg Virus Disease/*immunology
Alanine Transaminase/blood ; Animals ; Antibodies, Viral/blood ; Immunoglobulin G/blood ; Immunohistochemistry ; Liver/pathology ; Lymphocyte Count ; Male ; Marburg Virus Disease/pathology ; Marburgvirus ; RNA, Viral/genetics ; Subcutaneous Absorption
Czasopismo naukowe
Tytuł :
Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation.
Autorzy :
Marzi A; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States.
Menicucci AR; Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA, United States.
Engelmann F; Department of Cell Molecular Biology, Northwestern University, Evanston, IL, United States.
Callison J; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States.
Horne EJ; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States.
Feldmann F; Rocky Mountain Veterinary Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States.
Jankeel A; Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA, United States.
Feldmann H; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States.
Messaoudi I; Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA, United States.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2019 Jan 22; Vol. 9, pp. 3071. Date of Electronic Publication: 2019 Jan 22 (Print Publication: 2018).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms :
Lymphocyte Activation*
Marburg Virus Disease/*prevention & control
Marburgvirus/*immunology
Viral Vaccines/*administration & dosage
Viremia/*prevention & control
Animals ; B-Lymphocytes/immunology ; Disease Models, Animal ; Female ; Humans ; Macaca fascicularis ; Male ; Marburg Virus Disease/immunology ; Marburg Virus Disease/virology ; T-Lymphocytes/immunology ; Treatment Outcome ; Vaccines, Synthetic/administration & dosage ; Vaccines, Synthetic/immunology ; Vesiculovirus/immunology ; Viral Envelope Proteins/genetics ; Viral Envelope Proteins/immunology ; Viral Vaccines/immunology ; Viremia/immunology ; Viremia/virology
Czasopismo naukowe
Tytuł :
Marburgviruses: An Update.
Autorzy :
Miraglia CM; University of Massachusetts Dartmouth.
Pokaż więcej
Źródło :
Laboratory medicine [Lab Med] 2019 Jan 01; Vol. 50 (1), pp. 16-28.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Marburg Virus Disease/*epidemiology
Marburgvirus/*pathogenicity
Animals ; Humans ; Marburg Virus Disease/pathology ; Marburg Virus Disease/therapy ; Marburg Virus Disease/transmission ; Marburgvirus/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies